How is Ublituximab-Xiiy dosed?
The dosage of Ublituximab-Xiiy intravenous route is as follows:
- The first dose lasts for at least 4 hours.
- The second dose is given 2 weeks after the first dose and lasts for at least 1 hour.
- Subsequent doses are 1 infusion every 24 weeks, with each infusion lasting for at least 1 hour.
What is the dosage form of Ublituximab-Xiiy?
Ublituximab-Xiiy is available in the form of a solution for intravenous administration.
How is Ublituximab-Xiiy administered?
Ublituximab-Xiiy is administered through a needle placed into one of the veins in a medical facility by a nurse or other trained health professional. The first dose lasts for at least 4 hours, followed by a second dose given 2 weeks after the first dose, which also lasts for at least 1 hour. Subsequent doses are given as 1 infusion every 24 weeks, with each infusion lasting for at least 1 hour.
What are common precautions when taking Ublituximab-Xiiy?
When taking Ublituximab-Xiiy intravenous route, it is important to be aware of the following precautions:
- Allergic Reactions: Inform your doctor about any unusual or allergic reactions to this medicine or any other medicines.
- Pediatric Use: Safety and efficacy have not been established in the pediatric population.
- Geriatric Use: No specific limitations in the elderly.
- Breastfeeding: Consult your doctor to weigh the potential benefits against the potential risks.
- Immunization Precautions: Avoid immunizations without your doctor's approval while using Ublituximab-Xiiy and for at least 4 weeks after stopping treatment.
- Live Vaccines: Complete any required live or live-attenuated vaccines at least 4 weeks before starting Ublituximab-Xiiy. Avoid non-live vaccines for at least 2 weeks before starting treatment and during the course of treatment.
- Polio Vaccine Precautions: Do not take oral polio vaccine, and avoid close contact with individuals who have taken oral polio vaccine within the last several months. Consider wearing a protective face mask if precautions cannot be taken.
Follow your doctor's instructions and seek their advice regarding any questions or concerns about the precautions when taking Ublituximab-Xiiy intravenous route.